Entity Dossier
Company

Pharmacia

Strategic Concepts & Mechanics

Cornerstone MoveGlobal Expansion from a Small-Country BaseCapital StrategyLand and Forest as Parallel Wealth StoreSignature MoveSpin-Off to Multiply, Never ConglomerateStrategic PatternDrug Repurposing as Market ExpansionCornerstone MoveControl Architecture Over Capital EfficiencyRisk DoctrineDebt Aversion from Farming RootsCapital StrategyCrisis-Price Entry as Wealth OriginCapital StrategyMultiple Expansion Through Proven OwnershipSignature MoveBack the CEO, Never Touch the ControlsSignature MoveFlee the State to Protect the CompanyCornerstone MoveEternal Horizon, Never Sell the CoreSignature MoveBuy at 'Nice Price Tags' During CrisisCornerstone MoveGenerational Transfer as Strategic Design, Not InheritanceSignature MoveExplorer-Billionaire: Eight Poles as IdentitySignature MovePeptide Hormone Bet Held for Seven DecadesCompetitive AdvantagePhilanthropy as Market-BuildingSignature MoveSavén: Educate the Market Before You Can Sell To ItOperating PrincipleClear-Cut Forestry vs Regrowth CapitalismSignature MoveJonsson: Wallenberg Network as Entry TicketSignature MoveMix: Shotgun Weddings Then Velvet-Rope FundraisingStrategic PatternDeregulation as Deal-Flow Gold RushCapital StrategySecondaries: Passing Companies Between PE FundsCornerstone MoveDouble Profitability or Don't EnterCornerstone MoveHunt Corporate Orphans After DeregulationCompetitive AdvantageCanadian Pension Model: Kill the MiddlemanIdentity & CultureSwedish Hero Immunity for Visible FoundersSignature MoveKarlsson: Ratos as the Anti-Fund — Hold Seventeen Years If NeededRisk DoctrineShort-Termism Trap: Five-Year Horizon vs Ten-Year PayoffSignature MoveDahlström: Low Leverage, Family Businesses, Patient CapitalCornerstone MoveDebt as the Engine, Company Pays Its Own RansomSignature MoveAhlström: Copenhagen Office to Dodge Swedish Capital ControlsCornerstone MoveFee Airbag: Get Paid Win or Lose

Primary Evidence

"Frederik and Eva Paulsen were pioneers in developing and selling drugs based on peptide hormones, which are small proteins secreted into the bloodstream from the pituitary gland. Eva Paulsen had experience in the field through previous research assignments. She had experimented with peptide hormones during her time at Pharmacia and Organon in Stockholm. Frederik and Eva Paulsen were convinced that the natural origin of peptide hormones could provide a more suitable basis for drug development than the steroids other companies were working with in the 1950s. They acquired a house in Malmö where they established a research department. In 1961, the research team made a major breakthrough when they learned to produce the peptide hormones vasopressin, also called antidiuretic hormone (ADH), and oxytocin synthetically and on an industrial scale. Ferring was one of the first companies in the world to succeed in this. The pharmaceutical company intended to treat diabetes insipidus (DI), not diabetes mellitus, which is commonly referred to as sugar sickness. DI increases urine production, which can lead to dehydration and pose a life-threatening risk if not treated. The synthetically manufactured drugs had fewer side effects, and the company was no longer dependent on the supply of pig pituitaries. After nearly seven decades, it has proven that the investment was right. To this day, peptide hormones are used in several of Ferring’s drugs."

Source:Sweden's Most Powerful Families - The Companies, the People, the Money

"Volvo’s then-CEO PG Gyllenhammar, who for many years was considered Sweden’s most powerful person, was one of those who bought into this reasoning. Among other things, he added the food company Procordia and the pharmaceutical company Pharmacia to his automobile business. A group like the forestry company Stora owned Swedish Match, which in turn not only produced matches, but also building materials, flooring, cardboard, and machines for fish gutting. Nokia manufactured such diverse products as televisions and rubber boots."

Source:The Finance Princes - The Story of the Swedish Venture Capitalists

Appears In Volumes